Data protection Impressum

Healthcare

Vaud-based medtech Comphya strengthens its clinical pipeline with fresh capital and prepares for pivotal trials in the United States.

Comphya raises CHF 7.5 million for its neurostimulation therapy to treat erectile dysfunction

14 July 2025

Geneva-based biotech Stalicla secures funding to advance precision medicine programs for autism and substance use disorders.

Addex Therapeutics leads CHF 2 million investment in Stalicla

14 July 2025

Geneva strengthens its support for breakthrough innovation with new FIF funding awarded to InTeeth, Speqqle, and 4D-PicoSense.

Three Geneva start-ups receive support from the FONGIT Innovation Fund

9 July 2025

Neuchâtel-based Aktiia has received FDA clearance for its Hilo Band, marking a global first in cuffless blood pressure monitoring for consumer use.

Aktiia’s Hilo band becomes first cuffless blood pressure monitor cleared by FDA

8 July 2025

Western Switzerland medtech start-ups ORamaVR and Compremium are progressing toward clinical validation of their technologies, targeting major improvements in surgical training and cancer diagnostics.

ORamaVR and Compremium unveil new tools for surgical training and diagnosis

2 July 2025

Two high-potential start-ups from Western Switzerland, HAYA Therapeutics and Neural Concept, have been named among the World Economic Forum’s 100 Technology Pioneers of 2025.

Two Lausanne-based start-ups named WEF Technology Pioneers in 2025

30 June 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (June 2025)

25 June 2025

Superlab Suisse will open a new laboratory at Campus Biotech in Geneva in January 2026, strengthening the region’s innovation infrastructure for life sciences start-ups.

Superlab expands to Geneva with new lab at Campus Biotech

25 June 2025

Backed by public funding and growing clinical interest, AirScale's sensor-based technology aims to simplify hospital workflows and improve patient care.

Bern-based medtech AirScale develops smart weighing solution for immobile patients

23 June 2025

Biotech KYLYS Aesthetics has raised CHF 1 million to advance clinical development of its next-generation hyaluronic acid medical devices for regenerative aesthetic medicine.

Geneva-based KYLYS raises CHF 1 million to advance regenerative aesthetic medicine

23 June 2025

1 2 3 4 5 6 7 8 9 10 … 24